Guidance for The Exone (XONE)
Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
---|---|---|---|---|---|---|
Q2 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q1 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q4 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q3 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q2 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q1 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
2015 | N/A | N/A | $58.00M – 66.00M | $59.90M | = Maintained | Details |
2015 | N/A | N/A | $40.00M | N/A | = Maintained | Details |
2015 | N/A | N/A | $58.00M – 66.00M | $58.13M | = Maintained | Details |
2014 | N/A | N/A | $55.00M – 60.00M | $61.60M | = Maintained | Details |
2014 | N/A | N/A | $55.00M – 60.00M | N/A | = Maintained | Details |
2014 | N/A | N/A | $45.00M – 50.00M | $54.16M | = Maintained | Details |
2013 | N/A | N/A | $48.00M – 52.00M | $49.70M | = Maintained | Details |
2013 | N/A | N/A | $48.00M – 52.00M | $50.50M | Lowered | Details |